Personalized Medicine’s Impact on Cancer Care

Jorge Cortes, MD

Video Categories: Personalized Medicine

Dr. Jorge Cortes provides examples of how personalized or precision medicine has positively impacted the approach to cancer care, citing the benefits of FLT3 inhibitors, IDH inhibitors, and MEK inhibitors, and other targeted treatments.
December 18, 2018

Financial Constraints to Molecular Biomarker Testing

Drs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.

September 2, 2015

Takeda Oncology Resources for Meeting the Challenges with Oncolytics

Dixie-Lee Esseltine, MD and George Mulligan, PhD describe how Takeda Oncology is working to provide resources that assist patients in understanding their disease and their goals of treatment